公司新闻
更多>>公司公告
更多>>- 12/03SOLVONIS THERAPEUTICS PLC--SVN-015 accepted into US NIDA funded programme
- 10/27Solvonis Therapeutics PLC--Appoints global biopharma leader Paul Carter
- 10/31Solvonis Therapeutics PLC--Total Voting Rights
- 10/31Solvonis Therapeutics PLC--Corporate Structure Update and Issue of Options
- 09/30Solvonis Therapeutics PLC--Half-year Report
- 08/28Solvonis Therapeutics PLC--Solvonis secures exclusive CNS collaboration
- 08/13Solvonis Therapeutics PLC--Media Coverage: Small Cap Idea profile
- 07/31Solvonis Therapeutics PLC--Total Voting Rights
- 07/22Solvonis Therapeutics PLC--Translational Bridging Studies
- 07/18Solvonis Therapeutics PLC--Exercise of warrants
- 07/14Solvonis Therapeutics PLC--Solvonis Chair to speak at Lucid Capital Markets
- 07/08Solvonis Therapeutics PLC--Holding(s) in Company
- 06/27Solvonis Therapeutics PLC--AGM Statement
- 06/27Solvonis Therapeutics PLC--Holding(s) in Company